Skip to main content
SpringerLink
Log in

Felbamate

  • Chapter
  • First Online:
Antiepileptic Drug Interactions

  • 1065 Accesses

Abstract

The pharmacokinetic characteristics of felbamate are described and the interaction effects of concomitant antiepileptic drugs on felbamate in terms of its pharmacokinetics and pharmacodynamics are highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wagner ML, Graves NM, Marienau K, Holmes GB, Remmel RP, Leppik IE. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate. Epilepsia. 1991;32:398–406.

    Article  CAS  PubMed  Google Scholar 

  2. Glue P, Banfield CR, Perhach JL, Mather GG, Racha JK, Levy RH. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation. Clin Pharmacokinet. 1997;33:214–24.

    Article  CAS  PubMed  Google Scholar 

  3. Hussein G, Troupin AS, Montouris G. Gabapentin interaction with felbamate. Neurology. 1996;47:1106.

    Article  CAS  PubMed  Google Scholar 

  4. Colucci R, Glue P, Holt B, Babfield C, Reidenberg P, Meechan JW, Pai S, Nomeir A, Lim J, Lin CC, Affrime MB. Effect of felbamate on the pharmacokinetics of lamotrigine. J Clin Pharmacol. 1996;36:634–8.

    Article  CAS  PubMed  Google Scholar 

  5. Hulsman JARJ, Rentmeester TW, Banfield CR, Reidenberg P, Colucci RD, Meehan JW, Radwanski E, Mojavarian P, Lin CC, Nezamis J, Affrime MB, Glue P. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine. Clin Pharmacol Ther. 1995;58:383–9.

    Article  CAS  PubMed  Google Scholar 

  6. Kelley MT, Walson PD, Cox S, Dusci LJ. Population pharmacokinetics of felbamate in children. Ther Drug Monit. 1997;19:29–36.

    Article  CAS  PubMed  Google Scholar 

  7. Wagner ML, Graves NM, Leppik IE, Remmel RP, Shmaker RC, Ward D, Perhach JL. The effect of felbamate on valproic acid disposition. Clin Pharmacol Ther. 1994;56:494–502.

    Article  CAS  PubMed  Google Scholar 

  8. Reidenberg P, Glue P, Banfield C, Colucci R, Meehan J, Rey E, Radwanski E, Nomeir A, Lim J, Lin C, Guillaume M, Affrime MB. Pharmacokinetic interaction studies between felbamate and vigabatrin. Br J Clin Pharmacol. 1995;40:157–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Therapeutic Drug Monitoring Unit Department of Clinical and Experimental Epilepsy, UCL-Institute of Neurology, Queen Square, London, UK

    Philip N. Patsalos

  2. Chalfont Centre for Epilepsy Chalfont St Peter, Buckinghamshire, UK

    Philip N. Patsalos

Authors
  1. Philip N. Patsalos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Patsalos, P.N. (2016). Felbamate. In: Antiepileptic Drug Interactions. Springer, Cham. https://doi.org/10.1007/978-3-319-32909-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32909-3_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32908-6

  • Online ISBN: 978-3-319-32909-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation